InvestorsHub Logo
icon url

Jacquescode

08/05/20 10:51 AM

#24323 RE: Jacquescode #24322

Oops. Stocks instead of sticks. Haha
icon url

fantomphan

08/05/20 11:12 AM

#24324 RE: Jacquescode #24322

What was incorrect that I posted? My buddy listened and said they weren't even going to address the backlog until it was in a question. That $3 million was in everybody's "I think revs will be $12 to $15 million" predictions. I am a big boy and can make my own decisions. Give me the truth. I cant figure or calculate anything based on BS figures that they, not us, have thrown around. Hemo is correct, a record quarter for sure, subjectively in the best position ever (agreed) but it should be better and like Ping Pow writes (interesting no attacks on her) the sp should be higher, and would be if this was handled better. Peace.
icon url

Aliberto

08/05/20 11:58 AM

#24329 RE: Jacquescode #24322

Chan's statements in the conference call are shameful for a CEO and shameful for every rational-thinking person and shareholder of Cytosorbents (I am are shareholder !).

At the end of the first quarter, cytosorbents had a massive order backlog of around $ 2.7 million, and then the corona epidemic really started.

At the beginning of April, the "Emergency Use Authorization for Use in Patients with COVID-19 Infection" was obtained in the USA, and after this approval, some hospital in other regions of the world should have canceled orders or no longer needed the filter.

The US approval and the grazing corona epidemic in particular should have led to significantly more demand. No hospital on this planet will cancel an order in such a situation!

This is Chan's statement.
"And so in fact some of those, some of that backlog we never had a chance to fulfill, because those devices were not needed at the end of the day."

Chan should just take his hat and let a capable man take over his position!